CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 72 filers reported holding CONATUS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $782,000 | -50.5% | 134,881 | -63.5% | 0.00% | -50.0% |
Q2 2018 | $1,580,000 | -24.8% | 369,124 | +3.2% | 0.00% | -33.3% |
Q1 2018 | $2,100,000 | +20.3% | 357,679 | -5.4% | 0.00% | +50.0% |
Q4 2017 | $1,746,000 | -50.8% | 378,005 | -41.6% | 0.00% | -60.0% |
Q3 2017 | $3,551,000 | +6.6% | 646,833 | +11.8% | 0.01% | -16.7% |
Q2 2017 | $3,331,000 | -30.9% | 578,346 | -30.7% | 0.01% | -33.3% |
Q1 2017 | $4,818,000 | -4.1% | 834,945 | -12.4% | 0.01% | -18.2% |
Q4 2016 | $5,026,000 | +3920.8% | 953,622 | +2099.2% | 0.01% | – |
Q4 2015 | $125,000 | -95.0% | 43,362 | -92.2% | 0.00% | -100.0% |
Q3 2015 | $2,477,000 | +219.2% | 556,680 | +269.7% | 0.01% | +400.0% |
Q2 2015 | $776,000 | +2.4% | 150,589 | +39.1% | 0.00% | -50.0% |
Q4 2014 | $758,000 | +249.3% | 108,246 | +205.8% | 0.00% | +100.0% |
Q3 2014 | $217,000 | -73.3% | 35,400 | -64.6% | 0.00% | -50.0% |
Q1 2014 | $814,000 | -0.1% | 100,000 | -20.9% | 0.00% | -33.3% |
Q4 2013 | $815,000 | -50.8% | 126,348 | -23.4% | 0.00% | -40.0% |
Q3 2013 | $1,658,000 | – | 165,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kalos Management, Inc. | 47,500 | $12,000 | 0.01% |
Virtu Financial LLC | 94,842 | $25,000 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 467,425 | $121,000 | 0.00% |
REILLY FINANCIAL ADVISORS, LLC | 22,011 | $6,000 | 0.00% |
A.R.T. Advisors, LLC | 60,430 | $16,000 | 0.00% |
GOLDMAN SACHS GROUP INC | 25,350 | $7,000 | 0.00% |
MORGAN STANLEY | 1,019 | $0 | 0.00% |
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 24,900 | $6,000 | 0.00% |
WOLVERINE TRADING, LLC | 30,900 | $8,000 | 0.00% |
WOLVERINE TRADING, LLC | 26,779 | $7,000 | 0.00% |